- Our valuation model indicates that the company's fundamental data points to lower growth opportunities for the target.
2. The current stock trend is in a consolidation phasewith general momentum accumulation in the intermediate-term.
3. The current potential for an upward price swing is lower, awaiting a swing trading score of 4 or above.
4. No dividend history, not ideal for dividend-oriented buy-and-hold strategy.
Health Care | Pharmaceuticals and Biotechnology
BHC 5 Dimension Analysis
Analysis Instruction of BHC
Performance
| 1D | 1M | 3M | 6M | 1Y | |
| BHC | -0.24% | -0.12% | 13.05% | 13.83% | 12.59% |
| Avg of Sector | 1.82% | -7.85% | -12.10% | -8.81% | -11.27% |
| S&P 500 | -1.47% | -3.00% | -1.28% | 7.62% | 16.92% |